The CE mark is the first regulatory approval received ... associated with fibrinogen deficiency. The INTERCEPT red blood cell system is in late-stage clinical development. For more information ...
The CE mark is the first regulatory approval received for Cerus' next ... associated with fibrinogen deficiency. The INTERCEPT red blood cell system is in late-stage clinical development. For more ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback